Benchmark Starts ICU Medical (ICUI) at Buy; Macro Defensive Growth Characteristics
Tweet
Share
E-mailGet Alerts ICUI Hot Sheet
Price: $182.84 +0.17%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Benchmark initiates coverage on ICU Medical (NASDAQ: ICUI) with a Buy. PT $60.00.
Analyst, James Terwilliger, said, "We believe the aging of the population will drive an increase in the volume of medical and surgical related procedures and therefore an increase in the demand for ICUI’s disposable medical connection systems...12/31/11, ICUI had cash equivalents and marketable securities of $160 million with no long-term debt. The company had net accounts receivables of $47.7 million with inventories of $40.4 million."
For an analyst ratings summary and ratings history on ICU Medical click here. For more ratings news on ICU Medical click here.
Shares of ICU Medical closed at $48.25 yesterday.
Analyst, James Terwilliger, said, "We believe the aging of the population will drive an increase in the volume of medical and surgical related procedures and therefore an increase in the demand for ICUI’s disposable medical connection systems...12/31/11, ICUI had cash equivalents and marketable securities of $160 million with no long-term debt. The company had net accounts receivables of $47.7 million with inventories of $40.4 million."
For an analyst ratings summary and ratings history on ICU Medical click here. For more ratings news on ICU Medical click here.
Shares of ICU Medical closed at $48.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
- Keefe, Bruyette & Woods Resumes Toronto-Dominion Bank (TD:CN) (TD) at Market Perform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
